Sinopharm Holdings and Novartis China Elevate Strategic Collaboration: Redefining Health Service Ecosystem through 'Value-Based Retail'

Phoenix Trees Overlapping in Verdant Layers, River Breeze Brushing the Shore, Witness a New Chapter of Strategic Upgrade. Sinopharm Group Co., Ltd. and Novartis China, with the core concept of "Value Retail ▪ Born for Patients," have embarked on a new journey of strategic cooperation upgrade in Shanghai. Both parties have consistently adhered to a patient-centered development philosophy, promoting the continuous transformation and upgrading of retail pharmacies into "health solution service providers" by enhancing the professional service capabilities of pharmacists.

At the meeting, the leaders of both parties delivered sincere and highly infectious speeches.

Chen Hui, Vice President of Novartis China and Head of Retail, Emerging Markets, and the Commerce Department, stated: "Novartis is a globally leading pharmaceutical company dedicated to reimagining medicine to improve quality of life and extend human lifespan. We focus on addressing major and frequently occurring diseases in China by providing patients with innovative drugs and treatment solutions. Retail pharmacies have always been an important strategic partner for Novartis China. Enabling more patients to benefit and ensuring high-quality medicines and professional services reach more patients in China is a shared vision. Novartis will continue to collaborate closely with Sinopharm Group to set industry benchmarks, enhance patients' quality of life through innovative pharmaceutical services, and highlight the value of retail."

Wu Yijian, Vice President of Sinopharm Group, emphasized: "The concept of value retail continues the strategic consistency that Sinopharm Group and Novartis have always maintained. Both parties will continue to join hands, always centering on patients, closely cooperate with the industry, continuously innovate and iterate, achieve the original vision of serving patients, and realize high-quality development of enterprises."

During the meeting, a frontline pharmacist from Sinopharm Group Co., Ltd. shared "Excellent Practice Cases of Professional Services for Out-of-Hospital Patients."

As the core promoter of the value retail strategy, Wang Junxing, head of Novartis China's retail division, pointed out: "The transformation of healthcare scenarios is driving the upgrading and transformation of pharmacy services. Patients' demand for professional health consultants has surpassed traditional drug supply. Over the past five years, the in-depth cooperation between Novartis and Sinopharm Group Co., Ltd. has empowered more than a hundred 'gold medal pharmacists' in disease areas such as hypertension and immunology, providing patients with full-course disease management services and extending innovative treatment solutions to more patients."

Contributed by: Retail Medical Development Department